Neuroscience, Neuromodulation, Neural Implants.
peer-reviewed research.) Before launching into the longer report, here are a couple of developments that launched a more hopeful 2021. RECENT DEVELOPMENTS Cogito Therapeutics kicked off 2021 with the announcement of the company’s FDA “breakthrough” approval for a neurostim treatment for Alzheimer’s